Melola Discovery

← Melola Discovery

Jurnal

Optimasi Kadar Fenilbutazon dalam Pembawa Vesikular Etosom (Optimization of Concentration of Phenylbutazone in Ethosomes Vesicular Carrier)

MEDULA (JURNAL ILMIAH FAKULTAS KEDOKTERAN UNIVERSITAS HALU OLEO) · Vol. 7 No. 2 (2020)

DOI
10.46496/medula.v7i2.11968
ISSN
2443-0218, 2339-1006
Published
2020-05-01
Publisher
Halu Oleo University
Language
eng

Abstract

Background: Phenylbutazone is a class of non-steroidal anti-inflammatory drugs (NSAIDs) used in the treatment of rheumatoid arthritis. Phenylbutazone is used by the transdermal route to reduce the irritating effect on the gastrointestinal tract. Purpose: This study aims to obtain phenylbutazone suspensions with optimal levels in the ethosome vesicular carrier. Methods: Preparation was carried out by the hot method (40oC) and cold method (30oC) as well as variations in the concentration of phosphatidylcholine (2% and 3%) and ethanol (30%, 35%, and 40%). Characterization of vesicles, namely the shape and size of vesicles using optical microscopy and entrapment efficiency using the spectrophotometer method with λ maks 266.6 nm. Optimization of phenylbutazone levels was carried out at a concentration of 0.1%; 0.15%; 0.2%; and 0.25%. The optimum formula was obtained at a concentration of phosphatidylcholine 3% and ethanol 35% prepared by the hot method. Results:. The form of a Small Unilamellar Vesicle (SUV), a size of 23.7 nm, and entrapment efficiency is 88.358%. Optimization of phenylbutazone levels was obtained at a concentration of 0.1% with entrapment efficiency of 88.358%. Conclusion: The optimum level of phenylbutazone in the vesicular carrier ethosome was 0.1%.Keywords: ethosome, optimation, phenylbutazone, transdermal ABSTRAKLatar Belakang: Fenilbutazon merupakan golongan obat antiinflamasi non stroid (AINS) yang digunakan pada pengobatan penyakit rheumatoid arthritis. Fenilbutazon digunakan melalui rute transdermal untuk mengurangi efek iritasi pada saluran cerna. Tujuan: Penelitian ini bertujuan memperoleh suspensi fenilbutazon dengan kadar yang optimal dalam pembawa vesikular etosom. Metode: Preparasi dilakukan dengan metode panas (40oC) dan metode dingin (30oC) serta variasi konsentrasi fosfatidilkolin (2% dan 3%) dan etanol (30%, 35%, dan 40%). Karakterisasi vesikel yaitu bentuk dan ukuran vesikel menggunakan mikroskop optik serta efisiensi penjerapan menggunakan metode spektrofotometer pada λmaks 266,6 nm. Optimasi kadar fenilbutazon dilakukan pada konsentrasi 0,1%; 0,15%; 0,2%; dan 0,25%. Diperoleh formula optimum pada konsentrasi fosfatidilkolin 3% dan etanol 35% yang dipreparasi dengan metode panas Hasil: Vesikel yang diperoleh berbentuk Small Unilamellar Vesicle (SUV), ukuran 23,7 nm, dan efisiensi penjerapan 88,358%. Optimasi kadar fenilbutazon diperoleh pada konsentrasi 0,1% dengan efisiensi penjerapan 88,358%. Kesimpulan: Disimpulkan bahwa kadar optimum fenilbutazon dalam pembawa vesikular etosom adalah 0,1%.Kata kunci: etosom, optimasi, fenilbutazon, transdermal

Collaboration network of the authors

40 authors · 139 co-authorship links · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Halu Oleo
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Suryani SuryaniUniversitas Halu Oleo4
Rini HamsidiAffiliation unknown3
Sulastrianah SulastrianahAffiliation unknown3
Wa Ode Sitti ZubaydahUniversitas Halu Oleo3
Henny KasmawatiUniversitas Halu Oleo3
Sunandar IhsanUniversitas Halu Oleo3
Juminten SaiminAffiliation unknown2
Satrio WicaksonoAffiliation unknown2
Ruslin RuslinUniversitas Halu Oleo2
Mentarry BafadalAffiliation unknown2
Sahidin SahidinAffiliation unknown2
Adryan FristiohadyAffiliation unknown2
Rina AndrianiAffiliation unknown2
Yamin YaminUniversitas Halu Oleo2
Wahyuni WahyuniAffiliation unknown2
Fery Indradewi ArmadanyAffiliation unknown2
Rifa'atul MahmudahAffiliation unknown2
Muhammad Hajrul MalakaAffiliation unknown2
Ari SartinahUniversitas Halu Oleo2
Nur illiyin AkibAffiliation unknown2
Muhamad ZamrudAffiliation unknown1
Sudarman SudarmanAffiliation unknown1
Arfan ArfanUniversitas Halu Oleo1
Ardiyanti ArdiyantiAffiliation unknown1
Nurhayani HMAffiliation unknown1
Muhammad Juharisman SaputraAffiliation unknown1
Wa BaaneAffiliation unknown1
M. JahidingAffiliation unknown1
Mashuni MashuniAffiliation unknown1
Fitri Handayani HAffiliation unknown1
H HalikAffiliation unknown1
R RamlahAffiliation unknown1
Andi Nafisah Tendri Adjeng MallarangengAffiliation unknown1
Husnaeni HusnaeniAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://ojs.uho.ac.id/index.php/medula/oai, first harvested 31 Okt 2026, last seen 1 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Optimasi Kadar Fenilbutazon dalam Pembawa Vesikular Etosom  (Optimization of Concentration of Phenylbutazone in Ethosomes  Vesicular Carrier)</dc:title>
	<dc:creator>Akib, Nur Illiyyin</dc:creator>
	<dc:creator>Sahumena, Muhammad Handoyo</dc:creator>
	<dc:creator>Dawu, Yunita</dc:creator>
	<dc:creator>Aspadiah, Vica</dc:creator>
	<dc:creator>Hafizah, Indria</dc:creator>
	<dc:creator>Ritonga, Halimahtussaddiyah</dc:creator>
	<dc:description xml:lang="en-US">Background: Phenylbutazone is a class of non-steroidal anti-inflammatory drugs (NSAIDs) used in the treatment of rheumatoid arthritis. Phenylbutazone is used by the transdermal route to reduce the irritating effect on the gastrointestinal tract. Purpose: This study aims to obtain phenylbutazone suspensions with optimal levels in the ethosome vesicular carrier. Methods: Preparation was carried out by the hot method (40oC) and cold method (30oC) as well as variations in the concentration of phosphatidylcholine (2% and 3%) and ethanol (30%, 35%, and 40%). Characterization of vesicles, namely the shape and size of vesicles using optical microscopy and entrapment efficiency using the spectrophotometer method with λ maks 266.6 nm. Optimization of phenylbutazone levels was carried out at a concentration of 0.1%; 0.15%; 0.2%; and 0.25%. The optimum formula was obtained at a concentration of phosphatidylcholine 3% and ethanol 35% prepared by the hot method. Results:. The form of a Small Unilamellar Vesicle (SUV), a size of 23.7 nm, and entrapment efficiency is 88.358%. Optimization of phenylbutazone levels was obtained at a concentration of 0.1% with entrapment efficiency of 88.358%. Conclusion: The optimum level of phenylbutazone in the vesicular carrier ethosome was 0.1%.Keywords: ethosome, optimation, phenylbutazone, transdermal ABSTRAKLatar Belakang: Fenilbutazon merupakan golongan obat antiinflamasi non stroid (AINS) yang digunakan pada pengobatan penyakit rheumatoid arthritis. Fenilbutazon digunakan melalui rute transdermal untuk mengurangi efek iritasi pada saluran cerna. Tujuan: Penelitian ini bertujuan memperoleh suspensi fenilbutazon dengan kadar yang optimal dalam pembawa vesikular etosom. Metode: Preparasi dilakukan dengan metode panas (40oC) dan metode dingin (30oC) serta variasi konsentrasi fosfatidilkolin (2% dan 3%) dan etanol (30%, 35%, dan 40%). Karakterisasi vesikel yaitu bentuk dan ukuran vesikel menggunakan mikroskop optik serta efisiensi penjerapan menggunakan metode spektrofotometer pada λmaks 266,6 nm. Optimasi kadar fenilbutazon dilakukan pada konsentrasi 0,1%; 0,15%; 0,2%; dan 0,25%. Diperoleh formula optimum pada konsentrasi fosfatidilkolin 3% dan etanol 35% yang dipreparasi dengan metode panas Hasil: Vesikel yang diperoleh berbentuk Small Unilamellar Vesicle (SUV), ukuran 23,7 nm, dan efisiensi penjerapan 88,358%. Optimasi kadar fenilbutazon diperoleh pada konsentrasi 0,1% dengan efisiensi penjerapan 88,358%. Kesimpulan: Disimpulkan bahwa kadar optimum fenilbutazon dalam pembawa vesikular etosom adalah 0,1%.Kata kunci: etosom, optimasi, fenilbutazon, transdermal</dc:description>
	<dc:publisher xml:lang="en-US">Halu Oleo University</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2020-05-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ojs.uho.ac.id/index.php/medula/article/view/11968</dc:identifier>
	<dc:identifier>10.46496/medula.v7i2.11968</dc:identifier>
	<dc:source xml:lang="en-US">MEDULA (JURNAL ILMIAH FAKULTAS KEDOKTERAN UNIVERSITAS HALU OLEO); Vol 7, No 2 (2020)</dc:source>
	<dc:source>2443-0218</dc:source>
	<dc:source>2339-1006</dc:source>
	<dc:source>10.46496/medula.v7i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ojs.uho.ac.id/index.php/medula/article/view/11968/8423</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 MEDULA</dc:rights>
</oai_dc:dc>